An artificial intelligence model predicts how brain immune cells react to RNA and DNA nanoparticles, helping scientists design safer and more effective nucleic acid therapies faster.

An update from Veritas In Silico Inc. ( ($JP:130A) ) is now available. Veritas In Silico Inc. and Dexerials Corporation have announced a joint ...

FUJIFILM Corporation today announced that it has signed a joint research agreement with the National Cancer Center Japan, a Tokyo-based national institution recognized for its leadership in cancer ...

A Northwestern team transformed a common chemotherapy drug into a powerful, targeted cancer therapy using spherical nucleic ...

Discover key Q3 2025 earnings insights for Maravai LifeSciences. Learn about revenue trends, cost reductions, and growth outlook.

Jonathan Henninger, an assistant professor of biological sciences, is part of a growing movement in the life sciences exploring how ribonucleic acid, known as RNA, can be harnessed to develop ...

Scientists at Northwestern University in Evanston, Illinois, have used nanotechnology to re-engineer the molecular structure of a common chemotherapy drug to turn it into a wonderous cure for ...

By restructuring a common chemotherapy drug, scientists increased its potency by 20,000 times. In a significant step forward for cancer therapy, researchers at Northwestern University have redesigned ...

Ribosomes are the cell's protein factories, which read the genetic code and assemble the proteins that every organism needs ...

Drugs to treat inflammatory and autoimmune diseases - such as asthma, psoriasis, rheumatoid arthritis or Chrousos syndrome - ...